<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Surg.</journal-id>
<journal-title>Frontiers in Surgery</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Surg.</abbrev-journal-title>
<issn pub-type="epub">2296-875X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fsurg.2024.1364195</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Surgery</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Saliva stress biomarkers in ERCP trainees before and after familiarisation with ERCP on a virtual simulator</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Georgiou</surname><given-names>Konstantinos</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2547545/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Boyanov</surname><given-names>Nikola</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Thanasas</surname><given-names>Dimitrios</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Sandblom</surname><given-names>Gabriel</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/58402/overview" />
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Linardoutsos</surname><given-names>Dimitrios</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1598724/overview" />
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Enochsson</surname><given-names>Lars</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2427398/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>1st Department of Propaedeutic Surgery, Hippocrateion Athens General Hospital, Athens Medical School, National and Kapodistrian University of Athens</institution>, <addr-line>Athens</addr-line>, <country>Greece</country></aff>
<aff id="aff2"><label><sup>2</sup></label><addr-line>Medical Simulation Training Centre</addr-line>, <institution>Research Institute of Medical University of Plovdiv</institution>, <addr-line>Plovdiv</addr-line>, <country>Bulgaria</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Medical Physics Laboratory Simulation Centre, Athens Medical School, National and Kapodistrian University of Athens</institution>, <addr-line>Athens</addr-line>, <country>Greece</country></aff>
<aff id="aff4"><label><sup>4</sup></label><institution>Department of Clinical Science and Education S&#x00F6;dersjukhuset, Karolinska Institute</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff>
<aff id="aff5"><label><sup>5</sup></label><institution>Department of Surgery, S&#x00F6;dersjukhuset</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff>
<aff id="aff6"><label><sup>6</sup></label><institution>Department of Diagnostics and Intervention, Surgery, Ume&#x00E5; University</institution>, <addr-line>Ume&#x00E5;</addr-line>, <country>Sweden</country></aff>
<aff id="aff7"><label><sup>7</sup></label><institution>Department of Clinical Science, Interventions and Technology, Division of Orthopedics and Biotechnology, Karolinska Institutet</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country>.</aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Marina Yiasemidou, University of York, United Kingdom</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Dimitrios Damaskos, University of Edinburgh, United Kingdom</p>
<p>D&#x00F6;rte Wichmann, University of T&#x00FC;bingen, Germany</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Lars Enochsson <email>lars.enochsson@umu.se</email></corresp>
<fn fn-type="other" id="fn001"><label><sup>&#x2020;</sup></label><p>ORCID Lars Enochsson <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0001-8947-4736">orcid.org/0000-0001-8947-4736</ext-link></p></fn>
</author-notes>
<pub-date pub-type="epub"><day>17</day><month>06</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>11</volume><elocation-id>1364195</elocation-id>
<history>
<date date-type="received"><day>01</day><month>01</month><year>2024</year></date>
<date date-type="accepted"><day>06</day><month>06</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Georgiou, Boyanov, Thanasas, Sandblom, Linardoutsos and Enochsson.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Georgiou, Boyanov, Thanasas, Sandblom, Linardoutsos and Enochsson</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec><title>Background</title>
<p>Stress during the early ERCP learning curve may interfere with acquisition of skills during training. The purpose of this study was to compare stress biomarkers in the saliva of trainees before and after familiarisation with ERCP exercises on a virtual simulator.</p>
</sec>
<sec><title>Methods</title>
<p>Altogether 26 endoscopists under training, 14 women and 12 men, completed the three phases of this study: Phase 1. Three different ERCP procedures were performed on the simulator. Saliva for &#x03B1;-amylase (sAA), Chromogranin A (sCgA), and Cortisol (sC) were collected before (baseline), halfway through the exercise (ex.), and 10&#x2005;min after completion of the exercise (comp.); Phase 2. A three-week familiarisation period where at least 30 different cases were performed on the virtual ERCP simulator; and Phase 3. Identical to Phase 1 where saliva samples were once again collected at baseline, during, and after the exercise. Percentage differences in biomarker levels between baseline and exercise (Diff<sub>ex</sub>) and between baseline and completion (Diff<sub>comp</sub>) during Phase 1 and Phase 3 were calculated for each stress marker.</p>
</sec>
<sec><title>Results</title>
<p>Mean &#x0025; changes, Diff<sub>ex</sub> and Diff<sub>comp</sub>, were significantly positive (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) for all markers in both Phase 1 and Phase 3. Diff<sub>ex</sub> in Phase 1 was significantly greater than Diff<sub>ex</sub> in Phase 3 (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) for sAA and sCgA. Diff<sub>comp</sub> for sAA in Phase 1 was significantly greater than Diff<sub>comp</sub> in Phase 3 (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). No significant differences were found in sC concentration between Phases 1 and 3.</p>
</sec>
<sec><title>Conclusion</title>
<p>This study shows that familiarisation with the ERCP simulator greatly reduced stress as measured by the three saliva stress biomarkers used with sAA being the best. It also suggests that familiarisation with an ERCP simulator might reduce stress in the clinical setting.</p>
</sec>
</abstract>
<kwd-group>
<kwd>ERCP</kwd>
<kwd>virtual simulator</kwd>
<kwd>training</kwd>
<kwd>stress</kwd>
<kwd>saliva biomarkers</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="3"/><equation-count count="0"/><ref-count count="33"/><page-count count="7"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Visceral Surgery</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>ERCP is a technically demanding endoscopic procedure requiring a high level of expertise to provide effective and safe patient care. Somehow, trainees must be able to practice effectively without putting the safety of the patient in jeopardy. Simulator-based training is thus highly recommended (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>Virtual reality simulation is an established method for acquiring and improving technical and non-technical skills in a controlled, reproducible, and quantitative environment that replicates real psychological challenges and mental stress. Simulation training has been used to assess stress and to develop intraprocedural stress management (<xref ref-type="bibr" rid="B2">2</xref>). The complexity of stress mechanisms makes acute stress measurement difficult to quantify and interpret. There is no universally recognised non-invasive gold standard technique for the assessment of stress. Instead, subjective, and objective surrogate methods have been proposed, such as measuring acute changes in the autonomic nervous system (ANS). Furthermore, non-invasive measurement of actual stress during a clinical procedure is not practically feasible (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>There are objective biomarkers of stress in the blood and saliva. The use of blood biomarkers involves the invasive procedure of taking blood, whereas saliva sampling is relatively non-invasive and thus a better way to analyse stress. According to the literature, the most effective salivary biomarkers of stress are cortisol (sC), alpha-amylase (sAA), and chromogranin A (sCgA) (<xref ref-type="bibr" rid="B4">4</xref>). Since stress is not dichotomous there are no specific thresholds for these biomarkers that indicate a high level of stress (<xref ref-type="bibr" rid="B5">5</xref>). Furthermore, stress is usually associated with impaired performance which, in the clinical situation, could lead to complications. Moreover, it has been shown that trainees suffer greater stress than more experienced practitioners (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>When training individuals in colonoscopy, steeper learning curves and fewer complications have been observed when employing a simulator-based program in training (<xref ref-type="bibr" rid="B7">7</xref>). These benefits have yet to be shown for ERCP (<xref ref-type="bibr" rid="B8">8</xref>). Furthermore, in a recent systematic review on the use of simulators to acquire ERCP skills, only one study conformed with validation criteria (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Our primary objective was thus to non-invasively measure stress levels of ERCP trainees by means of saliva stress biomarkers before and after familiarisation with virtual reality (VR) ERCP simulation. A secondary outcome was to assess any differences in stress between men and women.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Materials and methods</title>
<sec id="s2a"><label>2.1</label><title>Participants</title>
<p>Fifty-one trainee residents aged 28&#x2013;34 years were enrolled. All participants were residents in gastroenterology and general surgery, without any previous experience in ERCP. Written informed consent was obtained from each participant. The experiments were performed at the Medical Simulation Training Centre at the Medical University, Plovdiv, Bulgaria.</p>
</sec>
<sec id="s2b"><label>2.2</label><title>Experiments procedure</title>
<sec id="s2b1"><label>2.2.1</label><title>Initial exercise: phase 1</title>
<p>All subjects answered a baseline questionnaire for information on demographic data and prior endoscopic or simulator experience. They conformed with the following inclusion criteria: (1) no current prescribed or non-prescription medication; (2) no flu or symptom of upper respiratory tract infection; (3) non-smoker; (4) no alcohol, coffee, or exercise within 12&#x2005;h prior to testing; and (5) no food or brushing of teeth within 1&#x2005;h of the experiment. A post-experiment questionnaire regarding the participant&#x0027;s perception of the project was answered.</p>
<p>After a rest period of 30&#x2005;min, a baseline saliva sample was collected using an unstimulated passive drool technique. The subjects then spent 30&#x2005;min getting used to the ERCP modules on the GI-Mentor II simulator (Surgical Science Sweden AB, Gothenburg, Sweden) as well as add-on software (guidewires <italic>etc</italic>). Then they watched a video prepared by the second author, demonstrating the three ERCP exercises to be performed in the hands-on session. They then performed virtual bile duct cannulation three times to become acquainted with the simulator. The participants then completed, to the best of their ability, the following three virtual ERCP exercises with increasing level of difficulty:
<list list-type="simple">
<list-item><label>a.</label><p><italic>ERCP Exercise 1: Bile duct stone removal (ERCP Module 1, Case Study 4)</italic>.</p></list-item>
</list></p>
<p>Deep cannulation of the bile duct (BD) with a sphincterotomy catheter, contrast injection to diagnose the common bile duct stone (CBDS), then sphincterotomy followed by stone extraction using an extraction balloon.</p>
<list list-type="simple">
<list-item><label>b.</label><p><italic>ERCP Exercise 2: Diagnosis of hilar stenosis, and brush cytology (ERCP Module 1, Case Study 2)</italic>.</p></list-item>
</list>
<p>Cannulation of the BD and insertion of a guidewire. Contrast injection to reveal hilar stenosis. After sphincterotomy, brush cytology of the stenosis is performed.</p>
<list list-type="simple">
<list-item><label>c.</label><p><italic>ERCP Exercise 3: Diagnosis of cystic bile duct leakage and treatment with placement of a bile duct stent (ERCP Module 2, Case Study 4)</italic>.</p></list-item>
</list>
<p>BD cannulation using a sphincterotomy catheter followed by contrast injection revealing cystic leakage. After sphincterotomy, a plastic stent is introduced to cover the site of the cystic duct leakage.</p>
<p>No mentor intervention was allowed during the exercise session. Halfway through the first exercise (Phase 1), an &#x201C;exercise&#x201D; saliva sample was collected, and 10&#x2005;min after completing the exercise a third &#x201C;completion&#x201D; saliva specimen was taken as before. The saliva samples were refrigerated and subsequently stored at &#x2212;20&#x2009;&#x00B0;C within 4&#x2005;h of collection pending analysis. Participants unable to complete the three ERCP exercises of Phase 1 were excluded as no comparison with the reciprocal exercises of Phase 3 could be achieved. Therefore, only the remaining 26 proceeded on to Phase 2.</p>
</sec>
<sec id="s2b2"><label>2.2.2</label><title>Familiarisation: phase 2</title>
<p>During the following three weeks, the participants remaining became familiar with the ERCP simulator by performing at will at least 30 procedures supervised by a mentor (not including the initial three exercise procedures in Phase 1).</p>
</sec>
<sec id="s2b3"><label>2.2.3</label><title>Repetition: phase 3</title>
<p>After familiarisation, the remaining participants completed the three exercises exactly as in Phase 1 described above, and new saliva specimens (baseline, exercise, and completion) were collected and stored for analysis.</p>
</sec>
</sec>
<sec id="s2c"><label>2.3</label><title>Data analysis</title>
<p>All saliva samples were assessed using commercially available kits. For salivary cortisol (SME-1- 3002 Salivary Cortisol Research ELISA kit) and for <italic>&#x03B1;</italic>-amylase (SME-1- 1902 Alpha-amylase Kinetic Reaction Kit Research) were used, both from Salimetrics, Carlsbad, CA, USA (<ext-link ext-link-type="uri" xlink:href="www.salimetrics.com">www.salimetrics.com</ext-link>). Human Chromogranin A (sCgA) was measured with an EIA Kit (Cat. No.: RSCYK070R, BioVendor GmbH Germany). Concentrations of the saliva biomarkers were determined following the manufacturer&#x0027;s instructions.</p>
<p>To reduce multifactorial stress bias from external factors, the percentage difference (Diff<sub>ex</sub>) of each saliva biomarker was calculated from its baseline and exercise values, as well as the corresponding difference (Diff<sub>comp</sub>) between baseline and completion values. Accordingly, Diff<sub>ex&#x2009;</sub>&#x003D;&#x2009;100&#x2009;&#x00D7;&#x2009;(Value<sub>ex</sub>&#x2212;Value<sub>bas</sub>)/Value<sub>bas</sub> and Diff<sub>comp</sub>&#x2009;&#x003D;&#x2009;100&#x2009;&#x00D7;&#x2009;(Value<sub>comp</sub>&#x2212;Value<sub>bas</sub>)/Value<sub>bas</sub>.</p>
</sec>
<sec id="s2d"><label>2.4</label><title>Statistical analysis</title>
<p>The normality of the collected data was tested using the Kolmogorov&#x2013;Smirnov test. The R software version 3.5.0 was used for statistical analysis (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>We used paired <italic>t</italic>-test to compare mean Diff<sub>ex</sub> between Phases 1 and 3 as well as between Diff<sub>comp</sub> between Phases 1 and 3. We also used one-sided t- test to determine whether mean Diff<sub>ex</sub> or Diff<sub>comp</sub> in Phases 1 and 3 were positive showing that saliva parameter values during exercise and completion were significantly greater than their corresponding baseline.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<p>Twenty-five of the 51 participants were unable to complete Phase 1 and were therefore excluded from the study. Thus, our final group consisted of 26 participants (12 men and 14 women), 7 were 20&#x2013;30 years of age and the remaining (<italic>n</italic>&#x2009;&#x003D;&#x2009;19) 30&#x2013;40 years of age.</p>
<p>All participants experienced saliva collection to be problem-free and did not cause distraction. The distribution of the collected data was tested using the Kolmogorov&#x2013;Smirnov test and found to be normal.</p>
<p>Diff<sub>ex</sub> and Diff<sub>comp</sub> values were calculated from the Phase 1 and Phase 3 saliva biomarker data. Thus, six percentage differences Diff<sub>ex</sub> and Diff<sub>comp</sub> for the three saliva biomarkers were estimated in Phase 1 and six in Phase 3 (see <xref ref-type="table" rid="T1">Tables&#x00A0;1</xref>&#x2013;<xref ref-type="table" rid="T3">3</xref>).</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Diff<sub>ex</sub>(&#x0025;) and diff<sub>comp</sub>(&#x0025;) for saliva biomarkers (mean&#x2009;&#x002B;&#x2009;SD) in phases 1 and 3.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">a-amylase</th>
<th valign="top" align="center" colspan="2">Phase 1</th>
<th valign="top" align="center" colspan="2">Phase 2</th>
<th valign="top" align="center" rowspan="2"><italic>p</italic>-value</th>
</tr>
<tr>
<th valign="top" align="center">Mean</th>
<th valign="top" align="center">SD</th>
<th valign="top" align="center">Mean</th>
<th valign="top" align="center">SD</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">185</td>
<td valign="top" align="center">457.3</td>
<td valign="top" align="center">8.6</td>
<td valign="top" align="center">53.2</td>
<td valign="top" align="center">&#x003C;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">264</td>
<td valign="top" align="center">585.3</td>
<td valign="top" align="center">28.7</td>
<td valign="top" align="center">83.1</td>
<td valign="top" align="center">&#x003C;0.05</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Chromogranin A</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">71</td>
<td valign="top" align="center">97.7</td>
<td valign="top" align="center">42.4</td>
<td valign="top" align="center">49.7</td>
<td valign="top" align="center">&#x003C;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">47.9</td>
<td valign="top" align="center">81.3</td>
<td valign="top" align="center">32.9</td>
<td valign="top" align="center">41.4</td>
<td valign="top" align="center">0.23</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Cortisol</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">31.4</td>
<td valign="top" align="center">32.3</td>
<td valign="top" align="center">22.5</td>
<td valign="top" align="center">33.7</td>
<td valign="top" align="center">0.18</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">46.4</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center">42</td>
<td valign="top" align="center">51.4</td>
<td valign="top" align="center">0.36</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Male group (<italic>n</italic>&#x2009;&#x003D;&#x2009;12): diff<sub>ex</sub>(&#x0025;) and diff<sub>comp</sub>(&#x0025;) (mean&#x2009;&#x002B;&#x2009;SD) for each saliva biomarker in phases 1 and 3.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">a-amylase</th>
<th valign="top" align="center" colspan="2">Phase 1</th>
<th valign="top" align="center" colspan="2">Phase 3</th>
<th valign="top" align="center" rowspan="2"><italic>p</italic>-value</th>
</tr>
<tr>
<th valign="top" align="center">Mean</th>
<th valign="top" align="center">SD</th>
<th valign="top" align="center">Mean</th>
<th valign="top" align="center">SD</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">&#x2212;4.4</td>
<td valign="top" align="center">28.2</td>
<td valign="top" align="center">&#x2212;5.1</td>
<td valign="top" align="center">36.2</td>
<td valign="top" align="center">0.47</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">56.6</td>
<td valign="top" align="center">92.3</td>
<td valign="top" align="center">30.7</td>
<td valign="top" align="center">113.4</td>
<td valign="top" align="center">0.27</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Chromogranin A</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">91.5</td>
<td valign="top" align="center">122</td>
<td valign="top" align="center">53.9</td>
<td valign="top" align="center">65.6</td>
<td valign="top" align="center">0.13</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">57.9</td>
<td valign="top" align="center">100.7</td>
<td valign="top" align="center">39.7</td>
<td valign="top" align="center">43.4</td>
<td valign="top" align="center">0.31</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Cortisol</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">33.2</td>
<td valign="top" align="center">35.7</td>
<td valign="top" align="center">31.6</td>
<td valign="top" align="center">30.3</td>
<td valign="top" align="center">0.46</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">46.2</td>
<td valign="top" align="center">36.7</td>
<td valign="top" align="center">56.2</td>
<td valign="top" align="center">66.7</td>
<td valign="top" align="center">0.33</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Female group (<italic>n</italic>&#x2009;&#x003D;&#x2009;14): diff<sub>ex</sub>(&#x0025;) and diff<sub>comp</sub>(&#x0025;) (mean&#x2009;&#x002B;&#x2009;SD) of for each saliva biomarker in phases 1 and 3.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">a-amylase</th>
<th valign="top" align="center" colspan="2">Phase 1</th>
<th valign="top" align="center" colspan="2">Phase 3</th>
<th valign="top" align="center" rowspan="2"><italic>p</italic>-value</th>
</tr>
<tr>
<th valign="top" align="center">Mean</th>
<th valign="top" align="center">SD</th>
<th valign="top" align="center">Mean</th>
<th valign="top" align="center">SD</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">347.4</td>
<td valign="top" align="center">583.1</td>
<td valign="top" align="center">20.3</td>
<td valign="top" align="center">63.3</td>
<td valign="top" align="center">&#x003C;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">441.8</td>
<td valign="top" align="center">760.2</td>
<td valign="top" align="center">27.1</td>
<td valign="top" align="center">48.8</td>
<td valign="top" align="center">&#x003C;0.05</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Chromogranin A</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">53.5</td>
<td valign="top" align="center">71.1</td>
<td valign="top" align="center">32.5</td>
<td valign="top" align="center">29.5</td>
<td valign="top" align="center">0.11</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">39.3</td>
<td valign="top" align="center">62.9</td>
<td valign="top" align="center">27.2</td>
<td valign="top" align="center">40.4</td>
<td valign="top" align="center">0.29</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Cortisol</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>ex</sub></td>
<td valign="top" align="center">29.9</td>
<td valign="top" align="center">30.4</td>
<td valign="top" align="center">14.7</td>
<td valign="top" align="center">35.5</td>
<td valign="top" align="center">0.12</td>
</tr>
<tr>
<td valign="top" align="left">Diff<sub>comp</sub></td>
<td valign="top" align="center">46.6</td>
<td valign="top" align="center">36.9</td>
<td valign="top" align="center">29.9</td>
<td valign="top" align="center">31.2</td>
<td valign="top" align="center">0.12</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s3a"><label>3.1</label><title>&#x03B1;-amylase</title>
<p>Mean Diff<sub>ex</sub> and Diff<sub>comp</sub> (&#x0025;&#x2009;&#x00B1;&#x2009;SD) for saliva <italic>&#x03B1;</italic>-amylase in Phase 1 were 185.0&#x2009;&#x00B1;&#x2009;457.3 and 264&#x2009;&#x00B1;&#x2009;585.3 respectively, both significantly positive (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). This suggests that &#x03B1;-Amylase is a stress biomarker since it increased during and immediately after the exercise session compared to baseline values. Mean Diff<sub>ex</sub> and Diff<sub>comp</sub> in Phase 1 (see above) were significantly greater than the corresponding figures in Phase 3 (8.6&#x2009;&#x00B1;&#x2009;53.2 and 28.7&#x2009;&#x00B1;&#x2009;83.1 resp, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<p>Mean Diff<sub>ex</sub> (&#x2212;4.4&#x2009;&#x00B1;&#x2009;28.2) and Diff<sub>comp</sub> (56.6&#x2009;&#x00B1;&#x2009;92.3) for men in Phase 1 were no different to the corresponding figures in Phase 3 (&#x2212;5.1&#x2009;&#x00B1;&#x2009;36.2. <italic>p</italic>&#x2009;&#x003D;&#x2009;0.47, and 30.7&#x2009;&#x00B1;&#x2009;113.4. <italic>p</italic>&#x2009;&#x003D;&#x2009;0.27 resp) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>).</p>
<p>For the women, mean Diff<sub>ex</sub> (347.4&#x2009;&#x00B1;&#x2009;583.1) and Diff<sub>comp</sub> (441.8&#x2009;&#x00B1;&#x2009;760.2) in Phase 1 were significantly different from the corresponding figures in Phase 3 (20.3&#x2009;&#x00B1;&#x2009;63.3 and 27.1&#x2009;&#x00B1;&#x2009;48.8, <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05) (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>).</p>
</sec>
<sec id="s3b"><label>3.2</label><title>Chromogranin A</title>
<p>Mean Diff<sub>ex</sub> and Diff<sub>comp</sub> for sCgA in Phase 1 were 71.0&#x2009;&#x00B1;&#x2009;97.7 and 47.9&#x2009;&#x00B1;&#x2009;81.3 respectively, both significantly positive (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). This again suggests that chromogranin A is an indicator of stress as it increased during and immediately after the exercise session compared to baseline. Mean Diff<sub>ex</sub> in Phase1 was significantly higher than Diff<sub>ex</sub> (42.4&#x2009;&#x00B1;&#x2009;49.7) in Phase 3 (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), whereas mean Diff<sub>comp</sub> in Phase 1 was not significantly different from mean Diff<sub>comp</sub> (32.9&#x2009;&#x00B1;&#x2009;41.4) in Phase 3 (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.23) (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<p>In the male group, mean Diff<sub>ex</sub> (91.5&#x2009;&#x00B1;&#x2009;122.0) and Diff<sub>comp</sub> (57.9&#x2009;&#x00B1;&#x2009;100.7) in Phase 1 were not significantly different from Diff<sub>ex</sub> (53.9&#x2009;&#x00B1;&#x2009;65.6) and Diff<sub>comp</sub> (39.7&#x2009;&#x00B1;&#x2009;43.4) values in Phase 3 (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.13 and <italic>p</italic>&#x2009;&#x003D;&#x2009;0.31 for Diff<sub>ex</sub> and Diff<sub>comp</sub> respectively) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>).</p>
<p>For the women, mean Diff<sub>ex</sub> (53.5&#x2009;&#x00B1;&#x2009;71.1) and Diff<sub>comp</sub> (39.3&#x2009;&#x00B1;&#x2009;62.9) in Phase 1 were not significantly different from mean Diff<sub>ex</sub> (32.5&#x2009;&#x00B1;&#x2009;29.5) and Diff<sub>comp</sub> (27.2&#x2009;&#x00B1;&#x2009;40.4) in Phase 3 (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.11 and <italic>p</italic>&#x2009;&#x003D;&#x2009;0.29 for Diff<sub>ex</sub> and Diff<sub>comp</sub> respectively) (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>).</p>
</sec>
<sec id="s3c"><label>3.3</label><title>Saliva cortisol</title>
<p>Mean Diff<sub>ex</sub> and Diff<sub>comp</sub> for saliva cortisol in Phase 1 were 31.4&#x2009;&#x00B1;&#x2009;32.3 and 46.4&#x2009;&#x00B1;&#x2009;36.0 respectively, both significantly positive (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.05), indicating that Cortisol is also a stress biomarker as it has increased during and immediately after the exercise session compared to baseline. Mean Diff<sub>ex</sub> and Diff<sub>comp</sub> in Phase 1 were not significantly different from Diff<sub>ex</sub> (22.5&#x2009;&#x00B1;&#x2009;33.7) and Diff<sub>comp</sub> (42.0&#x2009;&#x00B1;&#x2009;51.4) in Phase 3 (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.18 and <italic>p</italic>&#x2009;&#x003D;&#x2009;0.36 respectively) (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<p>The mean Diff<sub>ex</sub> (33.2&#x2009;&#x00B1;&#x2009;35.7) for men in Phase 1 was not significantly different from Diff<sub>ex</sub> (31.6&#x2009;&#x00B1;&#x2009;30.3) in Phase 3 (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.46), nor was Diff<sub>comp</sub> (46.2&#x2009;&#x00B1;&#x2009;36.7) in Phase 1 significantly different from Diff<sub>comp</sub> (56.2&#x2009;&#x00B1;&#x2009;66.7) in Phase 3 (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.33) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>).</p>
<p>Mean Diff<sub>ex</sub> (29.9&#x2009;&#x00B1;&#x2009;30.4) and Diff<sub>comp</sub> (46.6&#x2009;&#x00B1;&#x2009;36.9) values for the women in Phase 1 were not significantly different from the corresponding figures in Phase 3 (14.7&#x2009;&#x00B1;&#x2009;35.5 and 29.9&#x2009;&#x00B1;&#x2009;31.2, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.12 for both) (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>The saliva stress biomarkers sAA, sCgA, and sC reliably correlated with mental stress while training on an ERCP simulator. The most accurate prediction of degree of change is obtained by sAA. The response to acute stress involves a complex process which is mediated by the hypothalamic-pituitary-adrenal (HPA) axis, as well as psychological and social reactions.</p>
<p>In the clinical setting, acute stress has a direct impact on performance and patient safety. Endoscopists performing ERCP, frequently encounter highly complex and thus stressful situations. Stress assessment and coping is thus relevant and necessary in this field (<xref ref-type="bibr" rid="B2">2</xref>). Thus, the ability to implement a coping strategy to deal with stress is thus important for enhancing performance (<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>Stress is a psychological construct and thus inherently difficult to measure objectively in terms of physiological parameters. Methods assessing autonomic nervous system (ANS) responses in various organ systems have been suggested as surrogate stress markers. These markers include: (a) changes in heart rhythm, measured by heart rate (HR), heart rate variability (HRV), or inter-beat interval (IBI); (b) electrodermal activity (EDA) levels; (c) thermal activity; and (d) saliva stress biomarkers (<italic>i.e.,</italic> sAA, sCgA, sC, and secretory immunoglobulin A). There is a lack of consistent methodology that has led to rather inconclusive and, in certain cases, conflicting results (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>To our knowledge, this study is the first to use three commercially available saliva stress biomarkers in an ERCP simulation setting. No previous study has reported acute mental strain measurements during endoscopy in clinical and simulation settings (<xref ref-type="bibr" rid="B13">13</xref>). In this study, we concomitantly measured saliva a-amylase, saliva chromogranin A, and saliva cortisol, all of them potential stress biomarkers, in a reproducible virtual simulation setting (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>A previous study showed that the biomarkers we used have strong correlations with stress (<xref ref-type="bibr" rid="B3">3</xref>). sAA is secreted from the salivary glands but great intra-individual variations are observed (<xref ref-type="bibr" rid="B17">17</xref>). It has been suggested that sAA could be used as a surrogate marker of norepinephrine in a variety of stressful conditions (<xref ref-type="bibr" rid="B18">18</xref>). In contrast to sC, sAA activity is affected by salivary flow rate and pH (<xref ref-type="bibr" rid="B19">19</xref>). Furthermore, in a study stressful situations were associated with higher sAA levels (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>Chromogranin A (CgA) is a glycoprotein that mediates intracellular storage of catecholamines and is released together with these by the sympathetic nervous system into the blood circulation (<xref ref-type="bibr" rid="B21">21</xref>). Previous studies have shown that sCgA responds rapidly to mental stress such as psychosomatic stress [25], academic assessment stress, and computer operation psychological stress (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Furthermore, it has been observed that sCgA levels increase during mental stress but decrease during intermissions, suggesting that sCgA can be used for short-term assessment of mental workload (<xref ref-type="bibr" rid="B24">24</xref>). sCgA is a more accurate indicator than sC since it responds more rapidly and more sensitively to psychological stressors (<xref ref-type="bibr" rid="B12">12</xref>). Others, however, have questioned the ability of sCgA to measure stress and/or ANS activity (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>Plasma cortisol enters the saliva through passive diffusion leading to a stable plasma/saliva ratio. Saliva cortisol levels can thus be used to assess stress related HPA activity, and this has become the most widely used biomarker for studies on mental stress. Saliva cortisol levels begin to rise within 5&#x2005;min of an increase in plasma cortisol reaching a peak 31&#x2013;40&#x2005;min after the onset of the stressor, and saliva levels correlate strongly with plasma cortisol concentrations. Studies have shown that acute stress increases sC levels (<xref ref-type="bibr" rid="B3">3</xref>). Some studies have failed to observe such an increase (<xref ref-type="bibr" rid="B26">26</xref>) and even a reduction in cortisol level after stress has been reported (<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>The use of saliva stress biomarkers in this study, proved to be simple and without distraction and preferable to invasive methods such as blood sampling (<xref ref-type="bibr" rid="B3">3</xref>). Biochemical stress markers were elevated during Phase 1 <italic>i.e.</italic>, during the first attempts to perform ERCP simulator exercises, and decreased as the trainees became acquainted with the simulation environment. This should be considered when planning simulator and clinical training. There were also some differences between the male and female trainees.</p>
<p>As Diff<sub>ex</sub> and Diff<sub>comp</sub> in Phase 1 were all significantly positive, we conclude that sAA, sCgA, and sC may be used as stress biomarkers. Of these, the best stress marker appeared to be sAA as it showed the greater percentage increase compared to increases in sCgA and sC (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>). It is also evident that familiarisation with the ERCP simulator during Phase 2 led to a reduction in stress while performing exercise in Phase 3, as indicated by the biomarkers used.</p>
<p>Throughout the world, women are highly underrepresented in the field of advanced endoscopy (<xref ref-type="bibr" rid="B8">8</xref>). In this study, however, more women participated than men. The stress response appears to be lower in women than in men (<xref ref-type="bibr" rid="B27">27</xref>). It has been suggested that this could be caused by a stronger cortisol response in women in the luteal phase than in those in the follicular phase. The menstrual cycle should thus be taken into consideration when assessing the reaction to stress. The cortisol levels may also be affected by oral contraceptives (<xref ref-type="bibr" rid="B28">28</xref>). Thus, saliva secretion differs between the sexes, and may be due to variations in the secretion of gonadal steroids and ANS regulation (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Our results partially support this observation since sAA Diff<sub>ex</sub> and Diff<sub>comp</sub> in the women during Phase 1 were greater than the corresponding values in men. However, sCgA Diff<sub>ex</sub> and Diff<sub>comp</sub> were higher in men, and no difference was seen between men and women for sC (<xref ref-type="table" rid="T2">Tables&#x00A0;2</xref>, <xref ref-type="table" rid="T3">3</xref>). When comparing saliva results for sAA, sCgA, sC between Phase 1 and Phase 3, there were no differences in the male group, but sAA showed a statistically significant increase in the female group. Moreover, as can be seen from <xref ref-type="table" rid="T2">Tables&#x00A0;2</xref>, <xref ref-type="table" rid="T3">3</xref>, during Phase 3 both sexes had similar Diff<sub>ex</sub> and Diff<sub>comp</sub> for all saliva biomarkers measured (sAA, sCgA, sC).</p>
<p>It should be noted that performance in basic endoscopy does not necessarily correlate with ERCP performance, since no relationship between basic handling skills and therapeutic skills has been demonstrated (<xref ref-type="bibr" rid="B30">30</xref>). Furthermore, extrapolation of results from a simulator to the clinical setting should be made with extreme caution. For practical reasons, <italic>in vivo</italic> measurements of physical examination cannot routinely be measured. Endoscopy simulators could, however, play a role in the trainee screening process (<xref ref-type="bibr" rid="B31">31</xref>).</p>
<p>In this study, mean sCgA Diff<sub>ex</sub> and Diff<sub>comp</sub> during Phase 1 were significantly positive (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), suggesting that Chromogranin A may be used as a stress biomarker. We also saw that the percentage difference in sCgA between exercise and baseline in Phase 1 was significantly greater than the corresponding difference in Phase 3, indicating that familiarisation in Phase 2 reduced stress in Phase 3.</p>
<p>During Phase 1, mean sC Diff<sub>ex</sub> and Diff<sub>comp</sub> were significantly positive (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), suggesting that saliva cortisol may be used as a stress indicator. This finding concurs with the findings of a study assessing sAA and sC during acute mental stress in 51 surgeons in the OR (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>This study has some limitations. The sample size was small, and our findings must be interpreted with caution. Secondly, any delayed salivary cortisol response would have been missed and delay in saliva sampling may be necessary to fully detect stress-induced cortisol response (<xref ref-type="bibr" rid="B32">32</xref>). No comparison with the FES score was made, and finally, the study focused on simulated ERCP training only, so extrapolation to clinical practice is not feasible. Furthermore, another limitation of the study is that we did not check the oral hygiene of the participants. As it is suggested the latter could influence the accuracy of the saliva biomarkers.</p>
<p>Nevertheless, this study sheds some light on the feasibility of using non-invasive assessment of stress experienced by trainee endoscopists using easy to collect saliva biomarkers. Larger, controlled studies with participants that have different clinical experience is needed to further evaluate and monitor stress during simulation training using saliva biomarkers.</p>
<p>Finally, this was a laboratory study conducted in a controlled environment, whereas stress monitoring in the clinical setting is more complex due to the influence of social, cultural, and psychological factors (<xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="s5" sec-type="conclusions"><label>5</label><title>Conclusion</title>
<p>In conclusion, the use of saliva biomarkers for assessing mental stress was easy to implement and well-accepted by all participants in this virtual simulation ERCP training setting. Familiarisation with the ERCP simulator greatly reduced stress when performing ERCP exercises afterwards. The saliva stress biomarkers sAA, sCgA, and sC may all be used to assess mental stress while training on an ERCP simulator, but the best of the three, judging by the degree of change, appears to be sAA. No conclusive difference in stress response between men and women was observed. Further studies including a larger number of trainees with different levels of ERCP experience are needed to exploit performance enhancement and error reduction techniques in ERCP training.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s11" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>KG: Data curation, Methodology, Resources, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. NB: Data curation, Methodology, Project administration, Resources, Supervision, Writing &#x2013; review &#x0026; editing. DT: Data curation, Formal Analysis, Validation, Writing &#x2013; review &#x0026; editing. GS: Formal Analysis, Supervision, Writing &#x2013; review &#x0026; editing. DL: Writing &#x2013; review &#x0026; editing. LE: Conceptualization, Formal Analysis, Software, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>We would like to acknowledge Professor Evangelos Georgiou, Athens University, Greece for his inspiring coaching. We would also like to acknowledge Professor Blagoi Marinov for providing premises at Plovdiv University, Bulgaria for this study.</p>
</ack>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Campos</surname><given-names>ST</given-names></name><name><surname>Arvanitakis</surname><given-names>M</given-names></name><name><surname>Devi&#x00E8;re</surname><given-names>J</given-names></name></person-group>. <article-title>A portrait of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: current practices and opportunities for improvement</article-title>. <source>United European Gastroenterol J</source>. (<year>2023</year>) <volume>11</volume>:<fpage>350</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1002/ueg2.12377</pub-id><pub-id pub-id-type="pmid">37022193</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgiou</surname><given-names>K</given-names></name><name><surname>Larentzakis</surname><given-names>A</given-names></name><name><surname>Papavassiliou</surname><given-names>AG</given-names></name></person-group>. <article-title>Surgeons&#x2019; and surgical trainees&#x2019; acute stress in real operations or simulation: a systematic review</article-title>. <source>Surgeon</source>. (<year>2017</year>) <volume>15</volume>:<fpage>355</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.surge.2017.06.003</pub-id><pub-id pub-id-type="pmid">28716368</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyanov</surname><given-names>N</given-names></name><name><surname>Georgiou</surname><given-names>K</given-names></name><name><surname>Thanasas</surname><given-names>D</given-names></name><name><surname>Deneva</surname><given-names>T</given-names></name><name><surname>Oussi</surname><given-names>N</given-names></name><name><surname>Marinov</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Use of saliva stress biomarkers to estimate novice male endoscopist&#x2019;s stress during training in a high-end simulator</article-title>. <source>Scand J Gastroenterol</source>. (<year>2021</year>) <volume>56</volume>:<fpage>1380</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1080/00365521.2021.1965208</pub-id><pub-id pub-id-type="pmid">34424793</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chojnowska</surname><given-names>S</given-names></name><name><surname>Ptaszy&#x0144;ska-Sarosiek</surname><given-names>I</given-names></name><name><surname>K&#x0119;pka</surname><given-names>A</given-names></name><name><surname>Kna&#x015B;</surname><given-names>M</given-names></name><name><surname>Waszkiewicz</surname><given-names>N</given-names></name></person-group>. <article-title>Salivary biomarkers of stress, anxiety and depression</article-title>. <source>J Clin Med</source>. (<year>2021</year>) <volume>10</volume>:<fpage>517</fpage>. <pub-id pub-id-type="doi">10.3390/jcm10030517</pub-id><pub-id pub-id-type="pmid">33535653</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vos</surname><given-names>G</given-names></name><name><surname>Trinh</surname><given-names>K</given-names></name><name><surname>Sarnyai</surname><given-names>Z</given-names></name><name><surname>Rahimi Azghadi</surname><given-names>M</given-names></name></person-group>. <article-title>Generalizable machine learning for stress monitoring from wearable devices: a systematic literature review</article-title>. <source>Int J Med Inf</source>. (<year>2023</year>) <volume>173</volume>:<fpage>105026</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijmedinf.2023.105026</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anton</surname><given-names>NE</given-names></name><name><surname>Montero</surname><given-names>PN</given-names></name><name><surname>Howley</surname><given-names>LD</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Stefanidis</surname><given-names>D</given-names></name></person-group>. <article-title>What stress coping strategies are surgeons relying upon during surgery?</article-title> <source>Am J Surg</source>. (<year>2015</year>) <volume>210</volume>:<fpage>846</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjsurg.2015.04.002</pub-id><pub-id pub-id-type="pmid">26105802</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>AD</given-names></name><name><surname>Ekkelenkamp</surname><given-names>VE</given-names></name><name><surname>Haringsma</surname><given-names>J</given-names></name><name><surname>Schoon</surname><given-names>EJ</given-names></name><name><surname>de Man</surname><given-names>RA</given-names></name><name><surname>Kuipers</surname><given-names>EJ</given-names></name></person-group>. <article-title>Simulated colonoscopy training leads to improved performance during patient-based assessment</article-title>. <source>Gastrointest Endosc</source>. (<year>2015</year>) <volume>81</volume>:<fpage>630</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.gie.2014.09.014</pub-id><pub-id pub-id-type="pmid">25475901</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lekkerkerker</surname><given-names>SJ</given-names></name><name><surname>Voermans</surname><given-names>RP</given-names></name></person-group>. <article-title>EUS and ERCP training in Europe: time for simulation, optimization, and standardization</article-title>. <source>United European Gastroenterol J</source>. (<year>2023</year>) <volume>11</volume>:<fpage>407</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ueg2.12399</pub-id><pub-id pub-id-type="pmid">37151136</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgiou</surname><given-names>K</given-names></name><name><surname>Atliev</surname><given-names>KT</given-names></name><name><surname>Oussi</surname><given-names>N</given-names></name><name><surname>Boyanov</surname><given-names>N</given-names></name><name><surname>Sandblom</surname><given-names>G</given-names></name><name><surname>Enochsson</surname><given-names>L</given-names></name></person-group>. <article-title>The use of simulators to acquire ERCP skills: a systematic review</article-title>. <source>Ann Med Surg (Lond)</source>. (<year>2023</year>) <volume>85</volume>:<fpage>2924</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1097/MS9.0000000000000819</pub-id><pub-id pub-id-type="pmid">37363584</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><collab>R Core Team</collab>. <source>R: a language and environment for statistical computing</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name> (<year>2021</year>). <comment>Available online at</comment>: <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link> <comment>(Accessed June 09, 2024)</comment>.</citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wetzel</surname><given-names>CM</given-names></name><name><surname>Black</surname><given-names>SA</given-names></name><name><surname>Hanna</surname><given-names>GB</given-names></name><name><surname>Athanasiou</surname><given-names>T</given-names></name><name><surname>Kneebone</surname><given-names>RL</given-names></name><name><surname>Nestel</surname><given-names>D</given-names></name><etal/></person-group> <article-title>The effects of stress and coping on surgical performance during simulations</article-title>. <source>Ann Surg</source>. (<year>2010</year>) <volume>251</volume>:<fpage>171</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/SLA.0b013e3181b3b2be</pub-id><pub-id pub-id-type="pmid">20032721</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="thesis"><person-group person-group-type="author"><name><surname>Georgiou</surname><given-names>K</given-names></name></person-group>. <source>Stress indices in surgical simulation</source> (PhD Thesis). <publisher-name>National and Kapodistrian University of Athens</publisher-name>, <publisher-loc>Athens, Greece</publisher-loc> (<year>2019</year>).</citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mizota</surname><given-names>T</given-names></name><name><surname>Anton</surname><given-names>NE</given-names></name><name><surname>Huffman</surname><given-names>EM</given-names></name><name><surname>Guzman</surname><given-names>MJ</given-names></name><name><surname>Lane</surname><given-names>F</given-names></name><name><surname>Choi</surname><given-names>JN</given-names></name><etal/></person-group> <article-title>Development of a fundamentals of endoscopic surgery proficiency-based skills curriculum for general surgery residents</article-title>. <source>Surg Endosc</source>. (<year>2020</year>) <volume>34</volume>:<fpage>771</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00464-019-06827-6</pub-id><pub-id pub-id-type="pmid">31102077</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sadi</surname><given-names>H</given-names></name><name><surname>Finkelman</surname><given-names>M</given-names></name><name><surname>Rosenberg</surname><given-names>M</given-names></name></person-group>. <article-title>Salivary cortisol, salivary alpha amylase, and the dental anxiety scale</article-title>. <source>Anesth Prog</source>. (<year>2013</year>) <volume>60</volume>:<fpage>46</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.2344/0003-3006-60.2.46</pub-id><pub-id pub-id-type="pmid">23763559</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obayashi</surname><given-names>K</given-names></name></person-group>. <article-title>Salivary mental stress proteins</article-title>. <source>Clin Chim Acta</source>. (<year>2013</year>) <volume>425</volume>:<fpage>196</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2013.07.028</pub-id><pub-id pub-id-type="pmid">23939251</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reshma</surname><given-names>AP</given-names></name><name><surname>Arunachalam</surname><given-names>R</given-names></name><name><surname>Pillai</surname><given-names>JK</given-names></name><name><surname>Kurra</surname><given-names>SB</given-names></name><name><surname>Varkey</surname><given-names>VK</given-names></name><name><surname>Prince</surname><given-names>MJ</given-names></name></person-group>. <article-title>Chromogranin A: novel biomarker between periodontal disease and psychosocial stress</article-title>. <source>J Indian Soc Periodontol</source>. (<year>2013</year>) <volume>17</volume>:<fpage>214</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4103/0972-124X.113076</pub-id><pub-id pub-id-type="pmid">23869129</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vassiliou</surname><given-names>MC</given-names></name><name><surname>Kaneva</surname><given-names>PA</given-names></name><name><surname>Poulose</surname><given-names>BK</given-names></name><name><surname>Dunkin</surname><given-names>BJ</given-names></name><name><surname>Marks</surname><given-names>JM</given-names></name><name><surname>Sadik</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Global assessment of gastrointestinal endoscopic skills (GAGES): a valid measurement tool for technical skills in flexible endoscopy</article-title>. <source>Surg Endosc</source>. (<year>2010</year>) <volume>24</volume>:<fpage>1834</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s00464-010-0882-8</pub-id><pub-id pub-id-type="pmid">20112113</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dimsdale</surname><given-names>JE</given-names></name><name><surname>O&#x2019;Connor</surname><given-names>D</given-names></name><name><surname>Ziegler</surname><given-names>M</given-names></name><name><surname>Mills</surname><given-names>P</given-names></name></person-group>. <article-title>Does chromogranin a respond to short-term mild physiologic challenge?</article-title> <source>Neuropsychopharmacology</source>. (<year>1989</year>) <volume>2</volume>:<fpage>237</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/0893-133x(89)90027-4</pub-id><pub-id pub-id-type="pmid">2789663</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellagambi</surname><given-names>FG</given-names></name><name><surname>Degano</surname><given-names>I</given-names></name><name><surname>Ghimenti</surname><given-names>S</given-names></name><name><surname>Lomonaco</surname><given-names>T</given-names></name><name><surname>Dini</surname><given-names>V</given-names></name><name><surname>Romanelli</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Determination of salivary alpha-amylase and cortisol in psoriatic subjects undergoing the trier social stress test</article-title>. <source>Microchem J</source>. (<year>2018</year>) <volume>2018</volume>:<fpage>177</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.microc.2017.04.033</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>JA</given-names></name><name><surname>Veerman</surname><given-names>ECI</given-names></name><name><surname>de Geus</surname><given-names>EJ</given-names></name><name><surname>Proctor</surname><given-names>GB</given-names></name></person-group>. <article-title><italic>&#x03B1;</italic>-amylase as a reliable and convenient measure of sympathetic activity: don&#x2019;t start salivating just yet!</article-title> <source>Psychoneuroendocrinology</source>. (<year>2011</year>) <volume>36</volume>:<fpage>449</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2010.12.019</pub-id><pub-id pub-id-type="pmid">21295411</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgiou</surname><given-names>K</given-names></name><name><surname>Larentzakis</surname><given-names>AV</given-names></name><name><surname>Khamis</surname><given-names>NN</given-names></name><name><surname>Alsuhaibani</surname><given-names>GI</given-names></name><name><surname>Alaska</surname><given-names>YA</given-names></name><name><surname>Giallafos</surname><given-names>EJ</given-names></name></person-group>. <article-title>Can wearable devices accurately measure heart rate variability? A systematic review</article-title>. <source>Folia Med (Plovdiv)</source>. (<year>2018</year>) <volume>60</volume>:<fpage>7</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.2478/folmed-2018-0012</pub-id><pub-id pub-id-type="pmid">29668452</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakane</surname><given-names>H</given-names></name><name><surname>Asami</surname><given-names>O</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>N</given-names></name><name><surname>Kanno</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Salivary chromogranin A as an index of psychosomatic stress response</article-title>. <source>Biomed Res</source>. (<year>1998</year>) <volume>19</volume>:<fpage>401</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2220/biomedres.19.401</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakane</surname><given-names>H</given-names></name><name><surname>Asami</surname><given-names>O</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Ohira</surname><given-names>H</given-names></name></person-group>. <article-title>Effect of negative air ions on computer operation, anxiety and salivary chromogranin A-like immunoreactivity</article-title>. <source>Int J Psychophysiol</source>. (<year>2002</year>) <volume>46</volume>:<fpage>85</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-8760(02)00067-3</pub-id><pub-id pub-id-type="pmid">12374649</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanamaru</surname><given-names>Y</given-names></name><name><surname>Kikukawa</surname><given-names>A</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name></person-group>. <article-title>Salivary chromogranin-A as a marker of psychological stress during a cognitive test battery in humans</article-title>. <source>Stress</source>. (<year>2006</year>) <volume>9</volume>:<fpage>127</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1080/14769670600909594</pub-id><pub-id pub-id-type="pmid">17060047</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>S</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name><name><surname>Nozawa</surname><given-names>A</given-names></name><name><surname>Asano</surname><given-names>H</given-names></name><name><surname>Ide</surname><given-names>H</given-names></name></person-group>. <article-title>Characteristics of salivary chromogranin A as a short-term mental stress biomarker</article-title>. <source>Trans Jpn Soc Med Biol Eng</source>. (<year>2010</year>) <volume>48</volume>:<fpage>207</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.11239/jsmbe.48.207</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alobid</surname><given-names>I</given-names></name><name><surname>de Pablo</surname><given-names>J</given-names></name><name><surname>Mullol</surname><given-names>J</given-names></name><name><surname>Centellas</surname><given-names>S</given-names></name><name><surname>Parramon</surname><given-names>G</given-names></name><name><surname>Carrasco</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Increased cardiovascular and anxiety outcomes but not endocrine biomarkers of stress during performance of endoscopic sinus surgery: a pilot study among novice surgeons</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. (<year>2011</year>) <volume>137</volume>:<fpage>487</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1001/archoto.2011.60</pub-id><pub-id pub-id-type="pmid">21576560</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>&#x0160;piljak</surname><given-names>B</given-names></name><name><surname>Vilibi&#x0107;</surname><given-names>M</given-names></name><name><surname>Glavina</surname><given-names>A</given-names></name><name><surname>Crnkovi&#x0107;</surname><given-names>M</given-names></name><name><surname>&#x0160;e&#x0161;erko</surname><given-names>A</given-names></name><name><surname>Lugovi&#x0107;-Mihi&#x0107;</surname><given-names>L</given-names></name></person-group>. <article-title>A review of psychological stress among students and its assessment using salivary biomarkers</article-title>. <source>Behav Sci (Basel)</source>. (<year>2022</year>) <volume>12</volume>:<fpage>400</fpage>. <pub-id pub-id-type="doi">10.3390/bs12100400</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helbig</surname><given-names>S</given-names></name><name><surname>Backhaus</surname><given-names>J</given-names></name></person-group>. <article-title>Sex differences in a real academic stressor, cognitive appraisal and the cortisol response</article-title>. <source>Physiol Behav</source>. (<year>2017</year>) <volume>179</volume>:<fpage>67</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2017.05.027</pub-id><pub-id pub-id-type="pmid">28546084</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sangiorgio</surname><given-names>JPM</given-names></name><name><surname>Seixas</surname><given-names>GF</given-names></name><name><surname>De Paula Ramos</surname><given-names>S</given-names></name><name><surname>Dezan-Garbelini</surname><given-names>CC</given-names></name></person-group>. <article-title>Salivary levels of SIgA and perceived stress among dental students</article-title>. <source>J Health Biol Sci</source>. (<year>2017</year>) <volume>2017</volume>:<fpage>9</fpage>. <pub-id pub-id-type="doi">10.12662/2317-3076jhbs.v6i1.1561.p9-16.2018</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>J</given-names></name><name><surname>Lockett</surname><given-names>M</given-names></name></person-group>. <article-title>Training in therapeutic endoscopy: meeting present and future challenges</article-title>. <source>Frontline Gastroenterol</source>. (<year>2019</year>) <volume>10</volume>:<fpage>135</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1136/flgastro-2018-101086</pub-id><pub-id pub-id-type="pmid">31205653</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voiosu</surname><given-names>T</given-names></name><name><surname>Puscasu</surname><given-names>C</given-names></name><name><surname>Orlandini</surname><given-names>B</given-names></name><name><surname>Cavlina</surname><given-names>M</given-names></name><name><surname>Bekkali</surname><given-names>N</given-names></name><name><surname>Eusebi</surname><given-names>LH</given-names></name><etal/></person-group> <article-title>Motion training on a validated mechanical ERCP simulator improves novice endoscopist performance of selective cannulation: a multicenter trial</article-title>. <source>Endosc Int Open</source>. (<year>2021</year>) <volume>9</volume>:<fpage>E145</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1055/a-1315-1994</pub-id><pub-id pub-id-type="pmid">33532551</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>AP</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name></person-group>. <article-title>Biological and psychological markers of stress in humans: focus on the trier social stress test</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2014</year>) <volume>38</volume>:<fpage>94</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.11.005</pub-id><pub-id pub-id-type="pmid">24239854</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>S</given-names></name><name><surname>Gottumukkala</surname><given-names>R</given-names></name><name><surname>Katragadda</surname><given-names>S</given-names></name><name><surname>Bhupatiraju</surname><given-names>RT</given-names></name><name><surname>Ashkar</surname><given-names>Z</given-names></name><name><surname>Borst</surname><given-names>CW</given-names></name><etal/></person-group> <article-title>A multimodal sensor dataset for continuous stress detection of nurses in a hospital</article-title>. <source>Sci Data</source>. (<year>2022</year>) <volume>9</volume>:<fpage>255</fpage>. <pub-id pub-id-type="doi">10.1038/s41597-022-01361-y</pub-id><pub-id pub-id-type="pmid">35650267</pub-id></citation></ref></ref-list>
</back>
</article>